| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonography, Computed Tomographic | 57 | 2024 | 83 | 11.780 |
Why?
|
| Colonic Polyps | 34 | 2024 | 137 | 5.660 |
Why?
|
| Colorectal Neoplasms | 20 | 2020 | 1053 | 2.410 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 18 | 2020 | 461 | 2.160 |
Why?
|
| Tomography, X-Ray Computed | 41 | 2020 | 2585 | 1.840 |
Why?
|
| Colonic Neoplasms | 18 | 2014 | 579 | 1.520 |
Why?
|
| Sensitivity and Specificity | 38 | 2020 | 1922 | 1.200 |
Why?
|
| Imaging, Three-Dimensional | 17 | 2020 | 608 | 1.050 |
Why?
|
| Diagnostic Errors | 6 | 2017 | 157 | 0.970 |
Why?
|
| Radiography, Abdominal | 4 | 2022 | 63 | 0.900 |
Why?
|
| Mass Screening | 8 | 2020 | 696 | 0.830 |
Why?
|
| Colon | 14 | 2020 | 540 | 0.800 |
Why?
|
| Radiology | 4 | 2022 | 192 | 0.800 |
Why?
|
| Humans | 133 | 2024 | 93515 | 0.750 |
Why?
|
| Mesenteric Ischemia | 1 | 2022 | 9 | 0.740 |
Why?
|
| Abdominal Pain | 3 | 2020 | 143 | 0.680 |
Why?
|
| False Negative Reactions | 6 | 2020 | 59 | 0.670 |
Why?
|
| Colonoscopy | 9 | 2011 | 303 | 0.660 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2005 | 1261 | 0.610 |
Why?
|
| Quality Control | 2 | 2018 | 123 | 0.600 |
Why?
|
| Pattern Recognition, Automated | 7 | 2014 | 217 | 0.590 |
Why?
|
| Radiation Dosage | 3 | 2022 | 229 | 0.570 |
Why?
|
| Radiography | 14 | 2022 | 790 | 0.550 |
Why?
|
| Pancreas | 5 | 2013 | 258 | 0.530 |
Why?
|
| Radiographic Image Enhancement | 6 | 2012 | 449 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.500 |
Why?
|
| Movement | 2 | 2011 | 304 | 0.500 |
Why?
|
| Appendix | 3 | 2012 | 30 | 0.490 |
Why?
|
| Appendicitis | 2 | 2017 | 64 | 0.480 |
Why?
|
| Multidetector Computed Tomography | 2 | 2017 | 57 | 0.480 |
Why?
|
| Algorithms | 7 | 2010 | 1953 | 0.470 |
Why?
|
| Middle Aged | 52 | 2020 | 27573 | 0.450 |
Why?
|
| Adenocarcinoma | 7 | 2009 | 1173 | 0.440 |
Why?
|
| Reproducibility of Results | 15 | 2016 | 2715 | 0.440 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.440 |
Why?
|
| Professional Competence | 2 | 2012 | 66 | 0.440 |
Why?
|
| Male | 65 | 2020 | 44557 | 0.440 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.440 |
Why?
|
| False Positive Reactions | 8 | 2020 | 212 | 0.430 |
Why?
|
| Diagnostic Imaging | 4 | 2022 | 452 | 0.430 |
Why?
|
| Intestinal Obstruction | 3 | 2007 | 93 | 0.420 |
Why?
|
| Cecum | 3 | 2020 | 78 | 0.400 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 58 | 0.400 |
Why?
|
| Lung | 1 | 2020 | 1366 | 0.390 |
Why?
|
| Contrast Media | 8 | 2020 | 988 | 0.390 |
Why?
|
| Female | 63 | 2019 | 48702 | 0.380 |
Why?
|
| Air | 1 | 2012 | 63 | 0.370 |
Why?
|
| Renal Artery | 2 | 2011 | 45 | 0.370 |
Why?
|
| Colonic Diseases | 2 | 2007 | 59 | 0.360 |
Why?
|
| Technology, Radiologic | 1 | 2012 | 103 | 0.360 |
Why?
|
| Kidney | 3 | 2011 | 1111 | 0.360 |
Why?
|
| Health Policy | 1 | 2013 | 206 | 0.350 |
Why?
|
| Aged | 34 | 2020 | 20434 | 0.350 |
Why?
|
| Observer Variation | 8 | 2012 | 570 | 0.340 |
Why?
|
| Adult | 43 | 2020 | 27918 | 0.340 |
Why?
|
| Cathartics | 2 | 2011 | 27 | 0.330 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2001 | 15 | 0.330 |
Why?
|
| Citric Acid | 2 | 2011 | 47 | 0.330 |
Why?
|
| Collateral Circulation | 2 | 2001 | 37 | 0.320 |
Why?
|
| Intestine, Small | 2 | 2007 | 310 | 0.320 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2000 | 110 | 0.320 |
Why?
|
| Body Mass Index | 2 | 2013 | 811 | 0.310 |
Why?
|
| Liver Neoplasms | 10 | 2005 | 776 | 0.310 |
Why?
|
| Organometallic Compounds | 2 | 2011 | 139 | 0.310 |
Why?
|
| Neurofibromatosis 1 | 2 | 2000 | 42 | 0.300 |
Why?
|
| Ischemia | 2 | 2022 | 253 | 0.300 |
Why?
|
| Ultrasonography | 19 | 2002 | 702 | 0.290 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 482 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 626 | 0.280 |
Why?
|
| Portal Vein | 3 | 2001 | 119 | 0.280 |
Why?
|
| Insufflation | 2 | 2006 | 10 | 0.280 |
Why?
|
| Calcinosis | 7 | 2001 | 222 | 0.280 |
Why?
|
| Postoperative Complications | 5 | 2019 | 2562 | 0.280 |
Why?
|
| Diagnosis, Differential | 17 | 2014 | 1546 | 0.270 |
Why?
|
| United States | 16 | 2020 | 7622 | 0.270 |
Why?
|
| Liver Cirrhosis | 4 | 2006 | 273 | 0.270 |
Why?
|
| Incidental Findings | 1 | 2008 | 97 | 0.270 |
Why?
|
| Diverticulum | 2 | 2024 | 44 | 0.260 |
Why?
|
| Supine Position | 4 | 2011 | 34 | 0.260 |
Why?
|
| Image Enhancement | 4 | 2010 | 505 | 0.260 |
Why?
|
| Adenoma | 6 | 2014 | 258 | 0.250 |
Why?
|
| Aged, 80 and over | 14 | 2014 | 7061 | 0.250 |
Why?
|
| Prone Position | 4 | 2011 | 61 | 0.250 |
Why?
|
| Societies, Medical | 2 | 2016 | 621 | 0.250 |
Why?
|
| Abdominal Neoplasms | 3 | 2013 | 39 | 0.250 |
Why?
|
| Retrospective Studies | 18 | 2019 | 10164 | 0.240 |
Why?
|
| Software | 5 | 2011 | 670 | 0.240 |
Why?
|
| Dietary Fiber | 1 | 2006 | 46 | 0.240 |
Why?
|
| Enema | 3 | 2005 | 36 | 0.240 |
Why?
|
| Rectum | 3 | 2020 | 149 | 0.240 |
Why?
|
| Varicose Veins | 1 | 2006 | 9 | 0.240 |
Why?
|
| Ileocecal Valve | 1 | 2006 | 4 | 0.240 |
Why?
|
| Intestinal Perforation | 1 | 2006 | 36 | 0.240 |
Why?
|
| Hypertension, Portal | 1 | 2006 | 45 | 0.230 |
Why?
|
| Fluoroscopy | 3 | 1998 | 129 | 0.230 |
Why?
|
| Internet | 1 | 2008 | 337 | 0.230 |
Why?
|
| Pericardium | 1 | 2006 | 72 | 0.230 |
Why?
|
| Liver | 4 | 1999 | 1210 | 0.220 |
Why?
|
| Computer-Aided Design | 1 | 2005 | 17 | 0.220 |
Why?
|
| Feces | 1 | 2006 | 360 | 0.210 |
Why?
|
| Thoracic Neoplasms | 2 | 2001 | 65 | 0.200 |
Why?
|
| User-Computer Interface | 2 | 2002 | 189 | 0.200 |
Why?
|
| Deglutition Disorders | 3 | 2018 | 126 | 0.200 |
Why?
|
| Publishing | 1 | 2004 | 91 | 0.190 |
Why?
|
| Artificial Intelligence | 3 | 2008 | 391 | 0.190 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 225 | 0.180 |
Why?
|
| Ganglioneuroma | 2 | 2000 | 9 | 0.180 |
Why?
|
| Radiologists | 1 | 2022 | 53 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2012 | 3054 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 1053 | 0.170 |
Why?
|
| General Surgery | 1 | 2004 | 248 | 0.170 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2001 | 22 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2002 | 149 | 0.170 |
Why?
|
| Mesenteric Veins | 1 | 2001 | 36 | 0.170 |
Why?
|
| Predictive Value of Tests | 6 | 2012 | 1713 | 0.160 |
Why?
|
| Splenic Neoplasms | 2 | 1998 | 17 | 0.150 |
Why?
|
| Registries | 3 | 2020 | 990 | 0.150 |
Why?
|
| Esophagitis | 2 | 1991 | 40 | 0.150 |
Why?
|
| Polyps | 3 | 2007 | 26 | 0.150 |
Why?
|
| Pulmonary Veins | 1 | 2000 | 104 | 0.150 |
Why?
|
| Hernia, Ventral | 1 | 1999 | 28 | 0.140 |
Why?
|
| Laser Therapy | 2 | 1990 | 151 | 0.140 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2018 | 23 | 0.140 |
Why?
|
| Subthalamic Nucleus | 1 | 2018 | 23 | 0.140 |
Why?
|
| Radiography, Interventional | 2 | 1998 | 148 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 1998 | 225 | 0.140 |
Why?
|
| Surgical Mesh | 1 | 1999 | 125 | 0.140 |
Why?
|
| Colonic Pouches | 1 | 2019 | 97 | 0.130 |
Why?
|
| Pancreas Transplantation | 1 | 1998 | 104 | 0.130 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 115 | 0.130 |
Why?
|
| Intestinal Diseases | 3 | 1994 | 84 | 0.130 |
Why?
|
| Reference Values | 2 | 2012 | 608 | 0.130 |
Why?
|
| Pelvic Neoplasms | 2 | 2013 | 42 | 0.130 |
Why?
|
| Pandemics | 2 | 2020 | 873 | 0.130 |
Why?
|
| Laparoscopy | 2 | 2006 | 782 | 0.130 |
Why?
|
| Bile Ducts | 2 | 1990 | 61 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 378 | 0.130 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 89 | 0.130 |
Why?
|
| Malpractice | 1 | 2017 | 47 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 3476 | 0.120 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 327 | 0.120 |
Why?
|
| Iodides | 1 | 1995 | 18 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2018 | 175 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 260 | 0.120 |
Why?
|
| Documentation | 1 | 2016 | 97 | 0.120 |
Why?
|
| Peritoneal Diseases | 2 | 2013 | 15 | 0.110 |
Why?
|
| Living Donors | 1 | 1998 | 347 | 0.110 |
Why?
|
| Kidney Transplantation | 2 | 1998 | 870 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2011 | 822 | 0.110 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 115 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2016 | 218 | 0.110 |
Why?
|
| Occult Blood | 1 | 1994 | 27 | 0.110 |
Why?
|
| Cross-Over Studies | 2 | 2018 | 390 | 0.110 |
Why?
|
| ROC Curve | 4 | 2010 | 775 | 0.110 |
Why?
|
| Metformin | 1 | 1995 | 125 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2001 | 797 | 0.110 |
Why?
|
| Neoplasms | 1 | 2009 | 3169 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 306 | 0.100 |
Why?
|
| Colitis, Ulcerative | 2 | 2019 | 800 | 0.100 |
Why?
|
| Barium Sulfate | 4 | 2005 | 39 | 0.100 |
Why?
|
| Rectal Neoplasms | 2 | 2000 | 132 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 4 | 2005 | 715 | 0.100 |
Why?
|
| Time Factors | 6 | 2018 | 5410 | 0.100 |
Why?
|
| Incidence | 3 | 2013 | 1701 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2013 | 85 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 1994 | 145 | 0.100 |
Why?
|
| Intestinal Polyps | 3 | 2006 | 27 | 0.100 |
Why?
|
| Mesentery | 1 | 2013 | 46 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 1995 | 379 | 0.090 |
Why?
|
| Radiology Information Systems | 2 | 2016 | 78 | 0.090 |
Why?
|
| Gallstones | 1 | 1992 | 21 | 0.090 |
Why?
|
| Choristoma | 1 | 2013 | 59 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1987 | 418 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 1999 | 1194 | 0.090 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 50 | 0.090 |
Why?
|
| Pancreatitis | 1 | 2013 | 94 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1994 | 242 | 0.090 |
Why?
|
| Prevalence | 3 | 2014 | 1321 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2006 | 337 | 0.090 |
Why?
|
| Prospective Studies | 5 | 2018 | 4560 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 174 | 0.090 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1991 | 36 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 206 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2006 | 917 | 0.090 |
Why?
|
| Organ Size | 1 | 2012 | 362 | 0.090 |
Why?
|
| Intestinal Neoplasms | 2 | 1994 | 68 | 0.090 |
Why?
|
| Electrolytes | 1 | 2011 | 52 | 0.090 |
Why?
|
| Esophageal Neoplasms | 2 | 1991 | 344 | 0.090 |
Why?
|
| Esophagus | 1 | 1991 | 113 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2013 | 251 | 0.080 |
Why?
|
| Hemangioma | 2 | 1988 | 63 | 0.080 |
Why?
|
| Pyridoxal Phosphate | 2 | 2000 | 12 | 0.080 |
Why?
|
| Adolescent | 13 | 2013 | 9606 | 0.080 |
Why?
|
| Forecasting | 2 | 2003 | 293 | 0.080 |
Why?
|
| Edetic Acid | 2 | 2000 | 40 | 0.080 |
Why?
|
| Quality of Life | 1 | 2019 | 1780 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 2008 | 242 | 0.080 |
Why?
|
| Cysts | 3 | 1995 | 99 | 0.080 |
Why?
|
| Phosphates | 1 | 2011 | 165 | 0.080 |
Why?
|
| Catheterization | 2 | 1999 | 218 | 0.080 |
Why?
|
| Hyperplasia | 2 | 1987 | 147 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 3 | 2005 | 184 | 0.080 |
Why?
|
| Thrombosis | 1 | 1992 | 309 | 0.080 |
Why?
|
| Intestinal Mucosa | 2 | 2006 | 824 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2010 | 335 | 0.080 |
Why?
|
| Posture | 2 | 2006 | 123 | 0.070 |
Why?
|
| Bias | 1 | 2009 | 137 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 373 | 0.070 |
Why?
|
| Pharynx | 2 | 1985 | 44 | 0.070 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2008 | 1 | 0.070 |
Why?
|
| Iohexol | 2 | 1998 | 20 | 0.070 |
Why?
|
| Ovarian Cysts | 1 | 2008 | 15 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 413 | 0.070 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2008 | 19 | 0.070 |
Why?
|
| Nephrolithiasis | 1 | 2008 | 24 | 0.070 |
Why?
|
| Consumer Behavior | 1 | 2008 | 31 | 0.070 |
Why?
|
| Angiography | 7 | 1987 | 192 | 0.070 |
Why?
|
| Pharyngeal Diseases | 1 | 1988 | 10 | 0.070 |
Why?
|
| Deglutition | 2 | 1985 | 85 | 0.070 |
Why?
|
| Hernia, Hiatal | 1 | 2008 | 35 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1994 | 1448 | 0.070 |
Why?
|
| Medical Informatics | 1 | 2008 | 48 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 102 | 0.070 |
Why?
|
| Hemangioma, Cavernous | 1 | 1988 | 66 | 0.070 |
Why?
|
| Teaching | 1 | 2008 | 141 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1995 | 1229 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2013 | 2441 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2008 | 106 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2008 | 120 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2012 | 1103 | 0.060 |
Why?
|
| Quinidine | 1 | 1986 | 11 | 0.060 |
Why?
|
| Splenic Diseases | 1 | 1986 | 12 | 0.060 |
Why?
|
| Esophageal Diseases | 1 | 1986 | 25 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2006 | 159 | 0.060 |
Why?
|
| Benzylamines | 1 | 2006 | 17 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 425 | 0.060 |
Why?
|
| Surgical Instruments | 1 | 2006 | 62 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 660 | 0.060 |
Why?
|
| Azetidines | 1 | 2006 | 36 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2006 | 71 | 0.060 |
Why?
|
| Patient Compliance | 2 | 2007 | 237 | 0.060 |
Why?
|
| Larynx | 1 | 1985 | 35 | 0.060 |
Why?
|
| Mucocele | 1 | 1985 | 5 | 0.060 |
Why?
|
| Automation | 2 | 2006 | 105 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1991 | 1077 | 0.060 |
Why?
|
| Urologic Surgical Procedures | 1 | 2006 | 152 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 373 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 484 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2006 | 756 | 0.050 |
Why?
|
| Confusion | 1 | 2024 | 9 | 0.050 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 24 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2006 | 182 | 0.050 |
Why?
|
| Cystadenocarcinoma | 1 | 1983 | 12 | 0.050 |
Why?
|
| Cystadenoma | 1 | 1983 | 18 | 0.050 |
Why?
|
| Subtraction Technique | 1 | 2004 | 125 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2002 | 3830 | 0.050 |
Why?
|
| Hemangioendothelioma | 1 | 1983 | 9 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2006 | 270 | 0.050 |
Why?
|
| Injections, Intravenous | 3 | 2000 | 212 | 0.050 |
Why?
|
| Age Factors | 3 | 2012 | 1906 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2024 | 207 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2003 | 35 | 0.050 |
Why?
|
| Research | 1 | 2004 | 251 | 0.050 |
Why?
|
| Swine | 2 | 1997 | 588 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2006 | 457 | 0.050 |
Why?
|
| Hamartoma | 3 | 1987 | 33 | 0.050 |
Why?
|
| Heart Aneurysm | 1 | 1981 | 16 | 0.040 |
Why?
|
| Cause of Death | 1 | 2003 | 273 | 0.040 |
Why?
|
| Ureteral Obstruction | 1 | 2002 | 68 | 0.040 |
Why?
|
| CA-125 Antigen | 1 | 2001 | 21 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 417 | 0.040 |
Why?
|
| Disease Progression | 2 | 2005 | 1531 | 0.040 |
Why?
|
| Gastroenterology | 1 | 2003 | 157 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2000 | 75 | 0.040 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2020 | 64 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2001 | 118 | 0.040 |
Why?
|
| Radionuclide Imaging | 4 | 1987 | 189 | 0.040 |
Why?
|
| Stents | 1 | 2002 | 409 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 15 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2018 | 1729 | 0.040 |
Why?
|
| Ileostomy | 1 | 2019 | 28 | 0.040 |
Why?
|
| Hepatic Artery | 1 | 1999 | 82 | 0.040 |
Why?
|
| Body Fluids | 1 | 1999 | 35 | 0.040 |
Why?
|
| Renal Artery Obstruction | 1 | 1998 | 17 | 0.040 |
Why?
|
| Renal Veins | 1 | 1998 | 26 | 0.040 |
Why?
|
| Stomach Neoplasms | 2 | 1994 | 308 | 0.030 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 1998 | 20 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1998 | 99 | 0.030 |
Why?
|
| Abdomen | 1 | 1998 | 120 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 492 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1998 | 100 | 0.030 |
Why?
|
| Ureter | 1 | 1998 | 92 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 1981 | 650 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 455 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 1999 | 237 | 0.030 |
Why?
|
| Reoperation | 1 | 2019 | 702 | 0.030 |
Why?
|
| Adenoma, Islet Cell | 1 | 1995 | 28 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 1995 | 10 | 0.030 |
Why?
|
| Contraindications | 1 | 1995 | 67 | 0.030 |
Why?
|
| Recurrence | 1 | 1999 | 1190 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 948 | 0.030 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1995 | 15 | 0.030 |
Why?
|
| Survival Rate | 2 | 2013 | 1948 | 0.030 |
Why?
|
| Solubility | 1 | 1996 | 187 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 5899 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 2544 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 690 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1995 | 134 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 2017 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1995 | 278 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 9099 | 0.030 |
Why?
|
| Jejunal Neoplasms | 1 | 1994 | 9 | 0.030 |
Why?
|
| Child | 6 | 1987 | 7355 | 0.030 |
Why?
|
| Pneumoperitoneum | 1 | 1993 | 5 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 1995 | 504 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 449 | 0.020 |
Why?
|
| Animals | 5 | 1997 | 28155 | 0.020 |
Why?
|
| Prognosis | 2 | 2013 | 3911 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1987 | 295 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1914 | 0.020 |
Why?
|
| Biliary Tract | 1 | 1991 | 11 | 0.020 |
Why?
|
| Gastric Lavage | 1 | 2011 | 3 | 0.020 |
Why?
|
| Acute Disease | 1 | 1993 | 841 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1995 | 339 | 0.020 |
Why?
|
| Endoscopy | 1 | 1994 | 366 | 0.020 |
Why?
|
| Infant | 3 | 1987 | 3220 | 0.020 |
Why?
|
| Cholangiography | 1 | 1990 | 38 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2011 | 122 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 302 | 0.020 |
Why?
|
| Dogs | 1 | 1990 | 634 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2010 | 238 | 0.020 |
Why?
|
| Europe | 1 | 2009 | 337 | 0.020 |
Why?
|
| Syndrome | 1 | 1989 | 437 | 0.020 |
Why?
|
| Child, Preschool | 4 | 1987 | 3829 | 0.020 |
Why?
|
| Mesenteric Cyst | 1 | 1987 | 1 | 0.020 |
Why?
|
| Lymphangioma | 1 | 1987 | 15 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1987 | 10 | 0.020 |
Why?
|
| Brunner Glands | 1 | 1987 | 1 | 0.020 |
Why?
|
| Omentum | 1 | 1987 | 68 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 1987 | 34 | 0.020 |
Why?
|
| Neurofibroma | 1 | 1987 | 12 | 0.020 |
Why?
|
| Mesenchymoma | 1 | 1986 | 4 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 1987 | 25 | 0.020 |
Why?
|
| Lipoma | 1 | 1987 | 25 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1243 | 0.020 |
Why?
|
| Neurilemmoma | 1 | 1987 | 37 | 0.020 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 1986 | 9 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 2006 | 15 | 0.020 |
Why?
|
| Candidiasis | 1 | 1986 | 39 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1986 | 116 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 657 | 0.010 |
Why?
|
| Palate, Soft | 1 | 1985 | 5 | 0.010 |
Why?
|
| Epiglottis | 1 | 1985 | 6 | 0.010 |
Why?
|
| Rabbits | 1 | 1987 | 618 | 0.010 |
Why?
|
| Vocal Cords | 1 | 1985 | 26 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1985 | 49 | 0.010 |
Why?
|
| Spleen | 1 | 1986 | 374 | 0.010 |
Why?
|
| Tongue | 1 | 1985 | 58 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2005 | 50 | 0.010 |
Why?
|
| Warfarin | 1 | 2006 | 106 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1986 | 123 | 0.010 |
Why?
|
| Pneumoradiography | 1 | 2005 | 3 | 0.010 |
Why?
|
| Tablets | 1 | 1986 | 127 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1985 | 256 | 0.010 |
Why?
|
| Deoxycytidine | 1 | 2005 | 208 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 449 | 0.010 |
Why?
|
| Ileum | 1 | 1985 | 167 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1987 | 2479 | 0.010 |
Why?
|
| Bevacizumab | 1 | 2005 | 256 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 12 | 0.010 |
Why?
|
| Fuzzy Logic | 1 | 2004 | 16 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 1986 | 121 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1991 | 808 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 398 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 617 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1985 | 159 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2007 | 404 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1983 | 11 | 0.010 |
Why?
|
| Hemangiosarcoma | 1 | 1983 | 16 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1983 | 70 | 0.010 |
Why?
|
| Biopsy | 1 | 1987 | 1175 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1985 | 572 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 1170 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2802 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1983 | 101 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 64 | 0.010 |
Why?
|
| Drainage | 1 | 1983 | 170 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1981 | 22 | 0.010 |
Why?
|
| Heart Rupture | 1 | 1981 | 7 | 0.010 |
Why?
|
| Carcinoma | 1 | 1985 | 439 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1982 | 250 | 0.010 |
Why?
|
| Vomiting | 1 | 2000 | 108 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2005 | 1001 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1395 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 960 | 0.010 |
Why?
|
| Pain | 1 | 2000 | 414 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 484 | 0.010 |
Why?
|
| Necrosis | 1 | 1995 | 204 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1999 | 1118 | 0.010 |
Why?
|
| Methods | 1 | 1993 | 139 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2000 | 754 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 2365 | 0.010 |
Why?
|
| Heart Failure | 1 | 1983 | 1386 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 3147 | 0.010 |
Why?
|
| Cholecystitis | 1 | 1991 | 17 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1991 | 36 | 0.010 |
Why?
|
| Lithotripsy | 1 | 1991 | 43 | 0.010 |
Why?
|
| Cholestasis | 1 | 1991 | 44 | 0.010 |
Why?
|
| Urography | 1 | 1986 | 40 | 0.000 |
Why?
|
| Manometry | 1 | 1986 | 42 | 0.000 |
Why?
|
| Pressure | 1 | 1986 | 166 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1986 | 448 | 0.000 |
Why?
|
| Video Recording | 1 | 1984 | 212 | 0.000 |
Why?
|
| Aortography | 1 | 1982 | 57 | 0.000 |
Why?
|
| Aortic Valve Stenosis | 1 | 1982 | 147 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1986 | 2495 | 0.000 |
Why?
|